Fledrich, R., Abdelaal, T., Rasch, L., Bansal, V., Schütza, V., Brügger, B., . . . Sereda, M. W. (2018). Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy. Nature Portfolio.
Cita Chicago Style (17a ed.)Fledrich, R., et al. Targeting Myelin Lipid Metabolism as a Potential Therapeutic Strategy in a Model of CMT1A Neuropathy. Nature Portfolio, 2018.
Cita MLA (8a ed.)Fledrich, R., et al. Targeting Myelin Lipid Metabolism as a Potential Therapeutic Strategy in a Model of CMT1A Neuropathy. Nature Portfolio, 2018.
Precaución: Estas citas no son 100% exactas.